Trial Profile
Pneumococcal Vaccination to Accelerate Immune Recovery in Sepsis Survivors
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Mar 2024
Price :
$35
*
At a glance
- Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary)
- Indications Pneumococcal infections
- Focus Therapeutic Use
- Acronyms VACIRiSS
- 01 Aug 2023 Status changed from active, no longer recruiting to completed.
- 07 Jun 2023 Status changed from completed to active, no longer recruiting.
- 22 Jan 2023 Status changed from active, no longer recruiting to completed.